Cure My Disease

Don't miss your cure!

 Log in / Sign up

Quitting smoking may be easier when someone helps with life's other struggles — a trial puts the idea to the test

NCT ID NCT06651684

Disease control Sponsor: St. Justine's Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether a digital program called CanCEASE, combined with a health navigator who helps parents address unmet social needs like housing or food, can boost smoking-cessation rates. Around 1,000 parents who smoke and report at least one social risk will be randomly assigned to receive the program plus navigator support or usual care. The study measures quit rates, smoking intensity, and whether social needs improve over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a digital smoking-cessation intervention (CanCEASE) combined with support from a health navigator who helps address unmet social needs
What this could lead to
If it works, this approach could offer a practical way to help parents quit smoking by also tackling real-world barriers like housing or food insecurity.
What could go wrong
This is a behavioral intervention, not a drug, so results may vary widely. The trial relies on self-reported quitting and social-need resolution, which can be unreliable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Feb 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Parents or legal guardians aged ≥18 years, with child(ren) aged 0-17 years, attending a regular scheduled medical appointment in one of the study sites. * Pregnant patients aged ≥18 years who are parents or legal guardians of child(ren) aged 0-17 years coming in for an prenatal appointment. * Smokers with at least one self-reported social risk as assessed by validated screening questions on the domains employment, housing stability, ability to pay for utilities, financial resource strain, food security, transportation, childcare, parent education and health literacy. * Sufficiently proficient in French or English to understand and complete study questionnaires. Exclusion Criteria: * Families presenting at the clinic for an urgent medical issue. * Parents without at least one social risk. * If both parents smoke, only one parent will be eligible to participate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Smoking cessation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nicotine dependence Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Smoking cessation Tobacco dependence

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Maisonneuve-Rosemont Hospital

    RECRUITING

    Montreal, Quebec, H1T 2M4, Canada

  • Pediatric Clinic of the CHU Sainte-Justine

    RECRUITING

    Montreal, Quebec, H3T1C5, Canada

  • Pierre-Le Gardeur Hospital

    RECRUITING

    Montreal, Quebec, J6V 0E8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.